Windward Bio Group Insider Trades
NASDAQ: WWBHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 4 · $69.75M
- Sales
- 0 · $0
- Shares bought / sold
- 4.10M / 0
- Net activity
- Net buying $69.8 million
Windward Bio Group insider activity
Over the last 12 months, Windward Bio Group insiders reported 19 transactions on SEC Form 4: 4 open-market purchases and 0 sales. Insiders bought $69.8 million and sold $0 worth of stock, for net insider buying of $69.8 million. The most recent filing shows Stampacchia Otello (Director) buying 875,000 shares at $17.00 on Nov 16, 2026.
Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put WWB's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
WWB insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Nov 16, 2026 | Applebaum ScottChief Legal & Corp Dev Officer | Award | 33,206 | — | Form 4 |
| Nov 16, 2026 | Harris Kevin AndrewChief Operating Officer | Award | 33,206 | — | Form 4 |
| Nov 16, 2026 | Kapadia SandipDirector | Award | 100,000 | — | Form 4 |
| Nov 16, 2026 | Bonita David PDirector | Tax withholding | 232 | $3.94K | Form 4 |
| Nov 16, 2026 | Bonita David PDirector | Option exercise | 216,668 | $4.33K | Form 4 |
| Nov 16, 2026 | Bonita David PDirector | Conversion | 1,611,008 | — | Form 4 |
| Nov 16, 2026 | Bonita David PDirector | Conversion | 3,561,936 | — | Form 4 |
| Nov 16, 2026 | Bonita David PDirector | Buy | 1,176,471 | $20.00M | Form 4 |
| Nov 16, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP IX LLCDirector | Tax withholding | 232 | $3.94K | Form 4 |
| Nov 16, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP IX LLCDirector | Option exercise | 216,668 | $4.33K | Form 4 |
| Nov 16, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP IX LLCDirector | Conversion | 1,611,008 | — | Form 4 |
| Nov 16, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP IX LLCDirector | Conversion | 3,561,936 | — | Form 4 |
| Nov 16, 2026 | ORBIMED ADVISORS LLC & OrbiMed Capital GP IX LLCDirector | Buy | 1,176,471 | $20.00M | Form 4 |
| Nov 16, 2026 | Stampacchia OtelloDirector | Conversion | 531,634 | — | Form 4 |
| Nov 16, 2026 | Stampacchia OtelloDirector | Conversion | 531,632 | — | Form 4 |
| Nov 16, 2026 | Stampacchia OtelloDirector | Conversion | 1,262,626 | — | Form 4 |
| Nov 16, 2026 | Stampacchia OtelloDirector | Conversion | 1,262,628 | — | Form 4 |
| Nov 16, 2026 | Stampacchia OtelloDirector | Buy | 875,000 | $14.88M | Form 4 |
| Nov 16, 2026 | Stampacchia OtelloDirector | Buy | 875,000 | $14.88M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4